[TRVI] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TRVI] Trevi Therapeutics, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -7.74%
YoY- 6.87%
Quarter Report
TRVI's Result
TRVI's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 176 0 0 0 0 -
PBT -12,360 -10,910 -7,803 -7,711 -7,175 -6,408 -5,524 71.15%
Tax -8 -8 18 -13 -30 -7 -20 -45.74%
NP -12,352 -10,902 -7,821 -7,698 -7,145 -6,401 -5,504 71.49%
Tax Rate - - - - - - - -
Total Cost 12,352 10,902 7,997 7,698 7,145 6,401 5,504 71.49%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -4,443.75 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.12 -0.11 -0.08 -0.08 -0.07 -0.06 -0.06 58.80%
EPS Diluted -0.12 -0.11 -0.08 -0.08 -0.07 -0.06 -0.06 58.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.